Keyphrases
Temporal Effects
100%
Platelet Function
100%
Plasminogen Activator
100%
Prostaglandins
100%
Thrombolytic Agents
100%
Platelet Aggregation
80%
Prostaglandin E1 (PGE1)
80%
Co-infusion
40%
Streptokinase
40%
Plasmin Activity
40%
Therapeutic Agents
20%
Tissue Plasminogen Activator (t-PA)
20%
Inhibitory Effect
20%
Plasmin
20%
Recovery Period
20%
Enhanced Response
20%
Antiplatelet Agents
20%
Antiplatelet
20%
Thrombin
20%
Biphasic Effects
20%
Neuroscience
In Vivo
100%
Prostaglandin
100%
Plasminogen Activator
100%
Thrombolytic Drug
100%
Platelet
100%
Prostaglandin E1
80%
Thrombocyte Aggregation
80%
Prostacyclin
60%
Fibrinolysin
60%
Streptokinase
40%
Blood Plasma
40%
Adenosine Diphosphate
20%
Agonist
20%
Thrombin
20%
Tissue Plasminogen Activator
20%
Antiplatelet Drug
20%
Medicine and Dentistry
Plasminogen Activator
100%
Thrombocyte Function
100%
Thrombolytic Drug
100%
Prostaglandin
100%
Thrombocyte Aggregation
80%
Prostaglandin E1
80%
Infusion
60%
Fibrinolysin
60%
Prostacyclin
60%
Streptokinase
40%
Tissue Plasminogen Activator
20%
Ex Vivo
20%
Antiplatelet
20%
Thrombin
20%
Antiplatelet Drug
20%
Adenosine Diphosphate
20%
Pharmacology, Toxicology and Pharmaceutical Science
Fibrinolytic Agent
100%
Plasminogen Activator
100%
Prostaglandin
100%
Prostaglandin E1
80%
Plasmin
60%
Prostacyclin
60%
Leporidae
40%
Streptokinase
40%
Antiplatelet
20%
Antithrombocytic Agent
20%
Thrombin
20%
Tissue Plasminogen Activator
20%
Adenosine Diphosphate
20%